<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04378153</url>
  </required_header>
  <id_info>
    <org_study_id>SIMPLIFY-IP-19</org_study_id>
    <nct_id>NCT04378153</nct_id>
  </id_info>
  <brief_title>Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy</brief_title>
  <acronym>SIMPLIFY</acronym>
  <official_title>A Master Protocol to Test the Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy (SIMPLIFY)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>David Nichols, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cystic Fibrosis Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dartmouth-Hitchcock Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seattle Children's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite the increasingly common use of cystic fibrosis transmembrane conductance regulator&#xD;
      (CFTR) modulator therapies in treating CF, it is still largely unknown whether or not other&#xD;
      chronic therapies can be safely stopped. The SIMPLIFY study is being done to test whether or&#xD;
      not it is safe to stop taking inhaled hypertonic saline or Pulmozyme® (dornase alfa) in those&#xD;
      people that are also taking Trikafta™.&#xD;
&#xD;
      Trikafta (elexacaftor/tezacaftor/ivacaftor) is a combination CFTR modulator therapy that was&#xD;
      approved by the Food and Drug Administration for people with CF who have at least one F508del&#xD;
      mutation. The three drugs that make up Trikafta work together to allow many more chloride&#xD;
      ions to move into and out of the cells, improving the balance of salt and water in the lungs.&#xD;
      These changes result in better clearance of mucus from the lungs and improvements in lung&#xD;
      function.&#xD;
&#xD;
      Inhaled hypertonic saline and Pulmozyme (dornase alfa) also improve clearance of mucus from&#xD;
      the lungs to support lung function and have been available to people with CF for many years.&#xD;
      Both therapies are considered to be relatively burdensome and it is not known whether either&#xD;
      therapy can improve or maintain lung function above what is already gained through Trikafta&#xD;
      use.&#xD;
&#xD;
      The goal of the SIMPLIFY study is to get information about whether or not it is safe to stop&#xD;
      either inhaled hypertonic saline or Pulmozyme (dornase alfa) by testing if there is a change&#xD;
      in lung function in subjects with cystic fibrosis (CF) who are assigned to stop their chronic&#xD;
      medication (either hypertonic saline or Pulmozyme) as compared to those who are assigned to&#xD;
      keep taking their medication while continuing to take Trikafta.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This master protocol is designed to evaluate the independent effects of discontinuing&#xD;
      hypertonic saline (Study A) and dornase alfa (Study B) in people with cystic fibrosis (CF)&#xD;
      age 12 and older currently taking the highly effective modulator&#xD;
      elexacaftor/tezacaftor/ivacaftor (ETI). Study A and Study B are identical open label two-arm&#xD;
      randomized non-inferiority trials consisting of a 2-week screening period, randomization to&#xD;
      continue or discontinue hypertonic saline (Study A) or dornase alfa (Study B), followed by a&#xD;
      6-week study period. Subjects taking only hypertonic saline (HS) or dornase alfa at trial&#xD;
      entry will be randomized 1:1 to either continue or discontinue the applicable therapy (i.e.&#xD;
      HS or dornase alfa). Subjects taking both hypertonic saline and dornase alfa at study entry&#xD;
      will be randomized to participate in either Study A or Study B and will be randomized (1:1)&#xD;
      to continue or discontinue the applicable therapy (i.e. HS or dornase alfa). After completion&#xD;
      of the first study, eligible subjects may subsequently enroll in the alternative study.&#xD;
&#xD;
      Clinical outcomes (forced expiratory volume in 1 second [FEV1], antibiotic use, pulmonary&#xD;
      exacerbations, and patient reported outcomes), safety (adverse events) and the subject's&#xD;
      perception of how stopping HS or dornase alfa (or both) would impact their daily life will be&#xD;
      evaluated in all subjects. Additional outcome measurements will be conducted in a subset of&#xD;
      subjects at selected study sites:&#xD;
&#xD;
        -  Multiple Breath Washout (MBW) to evaluate changes in lung clearance index (LCI)&#xD;
&#xD;
        -  Mucociliary Clearance (MCC) using inhaled radio-labeled particles to evaluate changes in&#xD;
           mucociliary clearance&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 25, 2020</start_date>
  <completion_date type="Anticipated">May 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Absolute change in FEV1 % predicted from Week 0 to Week 6 in Hypertonic Saline (Study A) Therapy Arms</measure>
    <time_frame>Over the 6-week study period</time_frame>
    <description>Difference between hypertonic saline (HS) therapy arms (HS-discontinue - HS-continue) in the absolute change in FEV1 % predicted from Week 0 to Week 6.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Absolute change in FEV1 % predicted from Week 0 to Week 6 in Dornase Alfa (Study B) Therapy Arms</measure>
    <time_frame>Over the 6-week study period</time_frame>
    <description>Difference between dornase alfa (dnase) therapy arms (dnase-discontinue - dnase-continue) in the absolute change in FEV1 % predicted from Week 0 to Week 6.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of Adverse Events (AEs) in Hypertonic Saline (Study A) Therapy Arms</measure>
    <time_frame>Over the 6-week study period</time_frame>
    <description>Difference between hypertonic saline (HS) therapy arms (HS-discontinue - HS-continue) in the proportion of participants with at least one AE from Week 0 to Week 6.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Adverse Events (AEs) in Dornase Alfa (Study B) Therapy Arms</measure>
    <time_frame>Over the 6-week study period</time_frame>
    <description>Difference between dornase alfa (dnase) therapy arms (dnase-discontinue - dnase-continue) in the proportion of participants with at least one AE from Week 0 to Week 6.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Absolute Change in Respiratory Symptoms, as Measured by the CF Respiratory Symptoms Diary-Chronic Respiratory Infection Symptom Severity Score (CRISS) from Week 0 to Week 6 in Hypertonic Saline (Study A) Therapy Arms</measure>
    <time_frame>Over the 6-week study period</time_frame>
    <description>Difference between hypertonic saline (HS) therapy arms (HS-discontinue - HS-continue) in the absolute change in respiratory symptoms, as measured by the the CF Respiratory Symptoms Diary-Chronic Respiratory Infection Symptom Severity Score (CRISS) from Week 0 to Week 6. The Cystic Fibrosis Respiratory Symptoms Daily Diary asks a participant to state the extent of their 8 respiratory symptoms: difficulty breathing, feverishness, tiredness, chills or sweats, coughing, coughing up mucus, tightness in the chest and wheezing. Each respiratory symptom is assigned a score from 0-4 based on the response, with zero corresponding to the absence of the symptom and four corresponding to symptom being present 'a great deal' or 'extremely'. A summed score (range from 0-24) is calculated for each participant and converted to a final score with a range of 0 to 100, where the lowest scores indicate improvement of symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Absolute Change in Respiratory Symptoms, as Measured by the CF Respiratory Symptoms Diary-Chronic Respiratory Infection Symptom Severity Score (CRISS) from Week 0 to Week 6 in Dornase Alfa (Study B) Therapy Arms</measure>
    <time_frame>Over the 6-week study period</time_frame>
    <description>Difference between dornase alfa (dnase) therapy arms (dnase-discontinue - dnase-continue) in the absolute change in respiratory symptoms, as measured by the the CF Respiratory Symptoms Diary-Chronic Respiratory Infection Symptom Severity Score (CRISS) from Week 0 to Week 6. The Cystic Fibrosis Respiratory Symptoms Daily Diary asks a participant to state the extent of their 8 respiratory symptoms: difficulty breathing, feverishness, tiredness, chills or sweats, coughing, coughing up mucus, tightness in the chest and wheezing. Each respiratory symptom is assigned a score from 0-4 based on the response, with zero corresponding to the absence of the symptom and four corresponding to symptom being present 'a great deal' or 'extremely'. A summed score (range from 0-24) is calculated for each participant and converted to a final score with a range of 0 to 100, where the lowest scores indicate improvement of symptoms.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Cystic Fibrosis</condition>
  <arm_group>
    <arm_group_label>HS-Discontinue (Study A)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Discontinuation of current hypertonic saline (HS) therapy in Study A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HS-Continue (Study A)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuation of current hypertonic saline (HS) therapy in Study A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dnase-Discontinue (Study B)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Discontinuation of current dornase alfa (dnase) therapy in Study B</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dnase-Continue (Study B)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuation of current dornase alfa (dnase) therapy in Study B</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Discontinuation of hypertonic saline (HS)</intervention_name>
    <description>Discontinuation of current hypertonic saline (HS) therapy in Study A during 6-week study period.</description>
    <arm_group_label>HS-Discontinue (Study A)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Continuation of hypertonic saline (HS)</intervention_name>
    <description>Continuation of current hypertonic saline (HS) therapy in Study A during 6-week study period. Therapy is taken at least once daily according to each participant's pre-existing, clinically prescribed regimen (e.g., daily, twice daily). The concentration of HS is according to clinical prescription (e.g., 7% sodium chloride or 3.5% sodium chloride) and at least 3%.</description>
    <arm_group_label>HS-Continue (Study A)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Discontinuation of dornase alfa (dnase)</intervention_name>
    <description>Discontinuation of current dornase alfa (dnase) therapy in Study B during 6-week study period.</description>
    <arm_group_label>Dnase-Discontinue (Study B)</arm_group_label>
    <other_name>Discontinuation of pulmozyme</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Continuation of dornase alfa (dnase)</intervention_name>
    <description>Continuation of current dornase alfa (dnase) therapy in Study B during 6-week study period. Therapy is taken at least once daily according to each participant's pre-existing, clinically prescribed regimen (e.g., daily, twice daily).</description>
    <arm_group_label>Dnase-Continue (Study B)</arm_group_label>
    <other_name>Continuation of pulmozyme</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of CF.&#xD;
&#xD;
          -  Age ≥ 12 years at the Screening Visit.&#xD;
&#xD;
          -  Forced expiratory volume in 1 second (FEV1) ≥ 70 % predicted at the Screening Visit if&#xD;
             &lt; 18 years old, and ≥ 60 % predicted at Screening Visit if ≥ 18 years old.&#xD;
&#xD;
          -  Clinically stable with no significant changes in health status within the 7 days prior&#xD;
             to and including the Screening Visit.&#xD;
&#xD;
          -  Current treatment with elexacaftor/tezacaftor/ivacaftor (ETI) for at least the 90 days&#xD;
             prior to and including the Screening Visit and willing to continue daily use for the&#xD;
             duration of the study.&#xD;
&#xD;
          -  Currently taking hypertonic saline (at least 3%) and/or dornase alfa for at least the&#xD;
             90 days prior to and including the Screening Visit and willing to continue daily use&#xD;
             for the 2-week screening period.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Active smoking or vaping.&#xD;
&#xD;
          -  Use of an investigational drug within 28 days prior to and including the Screening&#xD;
             Visit.&#xD;
&#xD;
          -  Changes to chronic therapy (e.g., ibuprofen, azithromycin, inhaled tobramycin,&#xD;
             aztreonam lysine) within 28 days prior to and including the Screening Visit. This&#xD;
             includes new airway clearance routines.&#xD;
&#xD;
          -  Acute use of antibiotics (oral, inhaled or IV) or acute use of systemic&#xD;
             corticosteroids for respiratory tract symptoms within 7 days prior to and including&#xD;
             the Screening Visit.&#xD;
&#xD;
          -  Chronic use of systemic corticosteroids at a dose equivalent to ≥ 10mg per day of&#xD;
             prednisone within 28 days prior to and including the Screening Visit.&#xD;
&#xD;
          -  Antibiotic treatment for nontuberculous mycobacteria (NTM) within 28 days prior to and&#xD;
             including the Screening Visit.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicole Mayer-Hamblett, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington/Seattle Children's</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alex Gifford, MD, FCCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dartmouth-Hitchcock Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rachael Buckingham, BS</last_name>
    <phone>206-884-7517</phone>
    <email>rachael.buckingham@seattlechildrens.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anna Mead</last_name>
    <phone>884-7531</phone>
    <email>anna.mead@seattlechildrens.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justin Wade</last_name>
      <email>jdwade@uabmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Providence Alaska Medical Center</name>
      <address>
        <city>Anchorage</city>
        <state>Alaska</state>
        <zip>99508</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vicki Roberts</last_name>
      <email>vicki.roberts@providence.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tucson Cystic Fibrosis Center</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Osmara Molina</last_name>
      <email>omolina@email.arizona.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Arkansas Children's Hospital</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sheila Stroupe</last_name>
      <email>StroupeSL@archildrens.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Miller Children's and Women's Hospital Long Beach</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90806</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marylee Melendrez</last_name>
      <email>mmelendrez@memorialcare.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHOC Children's Hospital</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yvonne Chase</last_name>
      <email>YChase@choc.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Colleen Dunn</last_name>
      <email>cedunn@stanford.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rady Children's Hospital and Health Center at the University of California San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karl Perez</last_name>
      <email>kap018@ucsd.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of California, San Francisco - Adult Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Ellen Kleinhenz</last_name>
      <email>maryellen.kleinhenz@ucsf.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of California, San Francisco - Peds Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ngoc Ly</last_name>
      <email>Ngoc.Ly@ucsf.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Cross</last_name>
      <email>mary.cross@childrenscolorado.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Jewish Health</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80206</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alix Wilson</last_name>
      <email>wilsona@njhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yale University School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catalina Guzman</last_name>
      <email>catalina.guzman@yale.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebeccah Mercado</last_name>
      <email>rebeccahmercado@ufl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nemours Children's Clinic</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer (Jenn) Gafford</last_name>
      <email>Jennifer.gafford@nemours.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Central Florida Pulmonary Group</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Troy Koenig</last_name>
      <email>tkoenig@cfpulmonary.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Nemours Children's Clinic - Orlando</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32827</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristen Gibbs</last_name>
      <email>Kristen.Gibbs@nemours.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nemours Children's Clinic - Pensacola</name>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <zip>32514</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Davis</last_name>
      <email>Rebecca.Davis@nemours.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>All Children's Hospital</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diana Hodge</last_name>
      <email>dhodge6@jhmi.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tampa General Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Glunk</last_name>
      <email>hglunk@usf.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30327</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashleigh Streby</last_name>
      <email>ashleigh.streby@emory.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Luke's Cystic Fibrosis Center of Idaho</name>
      <address>
        <city>Boise</city>
        <state>Idaho</state>
        <zip>83702</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dixie Durham</last_name>
      <email>durhamd@slhs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Nelson</last_name>
      <email>rachel.nelson@northwestern.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>OSF Saint Francis Medical Center</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Scott</last_name>
      <email>Ashley.Scott@osfhealthcare.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Riley Hospital for Children</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Bendy</last_name>
      <email>lbendy@iupui.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Teresi</last_name>
      <email>mary-teresi@uiowa.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lawrence Scott</last_name>
      <email>lscott2@kumc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Kentucky</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40506</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Payne</last_name>
      <email>Christina.Payne@uky.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Burmester</last_name>
      <email>julie.burmester@louisville.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tulane University</name>
      <address>
        <city>Metairie</city>
        <state>Louisiana</state>
        <zip>70001</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Falgout</last_name>
      <email>nfalgout@tulane.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maine Medical Partners Pediatric Specialty Care</name>
      <address>
        <city>Portland</city>
        <state>Maine</state>
        <zip>04102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Edwards</last_name>
      <email>REdwards1@mmc.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>John Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Britany Zeglin</last_name>
      <email>bzeglin1@jhmi.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Boston Children's Hospital, Brigham &amp; Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Fowler</last_name>
      <email>Robert.fowler@childrens.harvard.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Michigan, Michigan Medicine</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dawn Kruse</last_name>
      <email>dmkruse@med.umich.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wayne State University Harper University Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debra Driscoll</last_name>
      <email>ddriscol@med.wayne.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helen DeVos Children's Hospital</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Mulroy</last_name>
      <email>heather.mulroy@spectrumhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospitals and Clinics of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Franck Thompson</last_name>
      <email>elizabeth.franckthompson@childrensmn.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Minnesota Cystic Fibrosis Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CF Trials Contact</last_name>
      <email>cftrials@umn.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Mercy Kansas City</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Candy Schmoll</last_name>
      <email>cschmoll@cmh.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tina Hicks</last_name>
      <email>hickst@wustl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Billings Clinic</name>
      <address>
        <city>Billings</city>
        <state>Montana</state>
        <zip>59101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jerimiah Lysinger</last_name>
      <email>JLysinger@billingsclinic.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dartmouth Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara A Rodgers</last_name>
      <email>Barbara.A.Rodgers@hitchcock.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Monmouth Medical Center</name>
      <address>
        <city>Eatontown</city>
        <state>New Jersey</state>
        <zip>07724</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bridget Marra</last_name>
      <email>bridget.marra@RWJBH.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Morristown Medical Center</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07960</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy Martinez</last_name>
      <email>nancy.martinez@atlantichealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rutgers - Robert Wood Johnson Medical School</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah McCloskey</last_name>
      <email>mcclosda@rwjms.rutgers.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cohen Children's Medical Center of New York</name>
      <address>
        <city>Lake Success</city>
        <state>New York</state>
        <zip>11042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Galvin</last_name>
      <email>sgalvin@northwell.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beth Israel Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Kukral</last_name>
      <email>anne.kukral@mountsinai.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Columbia University Cystic Fibrosis Program</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily DiMango</last_name>
      <email>ead3@cumc.columbia.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Rochester Medical Center Strong Memorial</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barb Johnson</last_name>
      <email>Barbara_Johnson@URMC.Rochester.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>SUNY Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Forell</last_name>
      <email>forellm@upstate.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>New York Medical College at Westchester Medical Center</name>
      <address>
        <city>Valhalla</city>
        <state>New York</state>
        <zip>10595</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zachary Messer</last_name>
      <email>Zachary_Messer@nymc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of North Carolina at Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Synger</last_name>
      <email>ashley_synger@med.unc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kay Powell</last_name>
      <email>kapowell@wakehealth.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Medical Center of Akron</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brenda Bourne</last_name>
      <email>bbourne@akronchildrens.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Thornton</last_name>
      <email>Kelly.Thornton@cchmc.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rainbow Babies and Children's Hospital/University Hospitals Cleveland Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44146</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen Hilliard</last_name>
      <email>kathleen.hilliard@uhhospitals.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Cystic Fibrosis Program</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dave Weaver</last_name>
      <email>weaverd@ccf.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diana Gilmore</last_name>
      <email>Diana.Gilmore@nationwidechildrens.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dayton Children's Hospital</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandy Bartosik</last_name>
      <email>bartosiks@childrensdayton.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oregon Health Sciences University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brendan Klein</last_name>
      <email>kleinb@ohsu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hershey Medical Center Pennsylvania State University</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diane M Kitch</last_name>
      <email>dkitch@pennstatehealth.psu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Molter</last_name>
      <email>melissa.molter@pennmedicine.upenn.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Hartigan</last_name>
      <email>elizabeth.hartigan@chp.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Warden</last_name>
      <email>jonesash@musc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dell Children's Medical Center of Central Texas</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78723</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Colleen Millian</last_name>
      <email>CaMillian@ascension.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern / Children's Health</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Casey Power</last_name>
      <email>casey.power@utsouthwestern.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Keller</last_name>
      <email>Ashley.Keller@UTSouthwestern.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cook Children's Medical Center</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Urbanek</last_name>
      <email>Heather.Urbanek@cookchildrens.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Center at Tyler</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debbie Fielder</last_name>
      <email>debbie.fielder@uthct.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Primary Children's Cystic Fibrosis Center</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84113</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane B Vroom</last_name>
      <email>jane.vroom@hsc.utah.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Vermont Medical Center</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Sweet</last_name>
      <email>julie.sweet@uvmhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erica Tharrington</last_name>
      <email>SFV6AB@hscmail.mcc.virginia.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret (Meg) Lessard</last_name>
      <email>margaret.lessard@vcuhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharon McNamara</last_name>
      <email>sharon.mcnamara@seattlechildrens.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Washington Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teresa Gambol</last_name>
      <email>TGambol@medicine.washington.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Providence Medical Group, Cystic Fibrosis Center</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joan Milton</last_name>
      <email>joan.e.milton@providence.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>West Virginia University - Morgantown</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tammy Clark</last_name>
      <email>tclark@hsc.wvu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophia Chiron Stevens</last_name>
      <email>scstevens@medicine.wisc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Roth</last_name>
      <email>lroth@mcw.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Froedtert &amp; Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Hubertz</last_name>
      <email>ehubertz@mcw.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>May 4, 2020</study_first_submitted>
  <study_first_submitted_qc>May 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2020</study_first_posted>
  <last_update_submitted>October 27, 2021</last_update_submitted>
  <last_update_submitted_qc>October 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Seattle Children's Hospital</investigator_affiliation>
    <investigator_full_name>David Nichols, MD</investigator_full_name>
    <investigator_title>Associate Professor of Pediatrics</investigator_title>
  </responsible_party>
  <keyword>Cystic Fibrosis</keyword>
  <keyword>CF</keyword>
  <keyword>Withdrawal</keyword>
  <keyword>Trikafta</keyword>
  <keyword>hypertonic saline</keyword>
  <keyword>dornase alfa</keyword>
  <keyword>pulmozyme</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

